Showing results (361-370 of 618) with videos related to
Sort By:
Pageof 62
Revue Medicale De Liege|February 10, 2022
[Bempedoïc acid, new cholesterol-lowering drug]A J Scheen, N Paquot, C WallemacqRevue Medicale De Liege|March 24, 2004
[Hematochromatosis and diabetes]V Thielen, N Paquot, A J ScheenRevue Medicale De Liege|January 14, 2005
[Percutaneous coronary angioplasty in diabetic patients. Part II: hopes based on endovascular prosthesis]F Warzée, V Legrand, A J ScheenRevue Medicale De Liege|April 11, 2002
[How I explore ... the risk of a patient developing type 2 diabetes]A J Scheen, N Paquot, B JandrainRevue Medicale De Liege|June 3, 2022
[Inflammation, obesity and type 2 diabetes. Role of the NLRP3 inflammasome and gut microbiota]N Esser, N PaquotRevue Medicale Suisse|September 16, 2006
[Drug therapy in the elderly. What should we know?]P Wotquenne, J Petermans, A J ScheenDiabetes & Metabolism|April 7, 2007
Abnormal glucose metabolism in patients treated with antipsychoticsA J Scheen, M A De HertRevue Medicale De Liege|August 17, 2006
[Do statins have a place for cardiovascular prevention in elderly people?]J Petermans, J Laperche, A J ScheenRevue Medicale De Liege|August 20, 2015
[STRENGTHS AND WEAKNESSES OF RANDOMISED CLINICAL TRIALS: EVOLVING CHANGES ACCORDING TO PERSONALIZED MEDICINE]Ph Ernest, B Jandrain, A J ScheenRevue Medicale De Liege|December 5, 2008
[Benefit-risk ratio of coronary drug-eluting stents. 1st part: evaluation in the global population]A Nyssen, V Legrand, A J ScheenPageof 62